Observations placeholder
Pemoline
Identifier
001516
Type of Spiritual Experience
Background
The figures come from the eHealthme website – see sources
A description of the experience
Pemoline - (Betanamin, Cylert , Tradon) was a medication used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy. Under the Convention on Psychotropic Substances, it is a Schedule IV drug. Pemoline was suspected of causing hepatotoxicity, so the FDA recommended that regular liver tests should be performed on those treated with it. Since receiving FDA approval in 1975, it has been linked with 21 cases of liver failure, of which 13 resulted in liver replacement or death. In 2005 the Food and Drug Administration (FDA) withdrew approval for pemoline due to pressure from public advocacy groups, which makes the following chart somewhat chilling reading. It is still being prescribed
On Mar, 29, 2015: 126 people reported to have side effects when taking Pemoline. Among them, 4 people (3.17%) have Hallucination.
On Dec, 29, 2016 127 people reported to have side effects when taking Pemoline.
Among them, 2 people (1.57%) have Hallucination, Tactile
On Dec, 29, 2016 127 people reported to have side effects when taking Pemoline.
Among them, 1 person (0.79%) has Hallucination, Auditory
On Dec, 07, 2016 766 people reported to have side effects when taking Cylert.
Among them, 2 people (0.26%) have Hallucinations